Biophysical investigation of the dual binding surfaces of human transcription factors FOXO4 and p53 Kim 2022 The FEBS Journal Wiley Online Library Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell FOX04 DRI 10mg Battle Born Peptides Frontiers Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. FOXO4 DRI (Proxofim) 10mg*10 vials Nexus peptides Your Gateway To High Quality Peptides